Full-Time

Head of Clinical Operations

Confirmed live in the last 24 hours

Alltrna

Alltrna

51-200 employees

Develops tRNA therapeutics for disease treatment

Biotechnology
Healthcare

Expert

Cambridge, MA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Google Cloud Platform
Requirements
  • Minimum 10 years of experience in clinical operations across at least 2 therapeutics areas, including rare diseases and oncology
  • Experience managing Phase 1 dose-finding trials (in Healthy Volunteers or in patients)
  • Experience leading patient-finding initiatives, especially those requiring genetic testing, to support clinical trial enrollment
  • Experience managing CROs and vendors both in the US and in international clinical trials
  • Experience in site initiation visits, site management, data cuts for publication and regulatory requirements
  • Understanding of the drug development process from IND to NDA/BLA
  • Dedication to collaborative work in a fast-paced environment; open-mindedness to shifting strategy in a data-guided manner
  • Ability to communicate effectively and efficiently and willingness to train other team-members within and outside of Clinical Operations
  • Experience in large Pharma and biotech and with biomarker-selected studies preferred but not required
  • Experience with at least one report is preferred, but a strong candidate with hands-on experience and a growth mindset will be considered
Responsibilities
  • Develop clinical operations strategy for each agent in development, either directly or by leading study staff depending on the stage of the pipeline.
  • Cross-functional collaboration to develop needed outputs such as protocols, annual safety reports and investigator brochure, clinical study reports, presentations, regulatory submissions, and publications.
  • Evaluate external collaborators including Contract Research Organizations (CROs) and sites and select the best candidates for each needed function. Develop vendor scope of work, contract, quality, monitoring, and budget.
  • Develop and lead patient finding and recruitment strategy, planning, and forecasting.
  • Develop and manage standard operating procedures (SOPs) for the organization and its external collaborators. Ensure GCP (Good Clin­i­cal Prac­tice) compliance.
  • Continuously evaluate performance of external collaborators and vendors, troubleshoot and recommend a path forward when challenges are encountered.
  • Develop and manage study timelines, working with internal partners (including but not limited to clinical development, clinical pharmacology and other quantitative functions, data management, biomarkers and translational, CMC, regulatory affairs, and project management).
  • Attend and, where appropriate, present at study site initiation meetings and study calls.

Alltrna focuses on developing tRNA therapeutics to treat diseases caused by genetic mutations. Their main product involves engineered tRNAs that can recognize and read stop codons, which are errors in the genetic code that lead to the production of incomplete proteins. By delivering the correct amino acids, these tRNAs help restore the production of full-length proteins, potentially addressing a wide range of diseases linked to nonsense mutations. Unlike other biotech companies, Alltrna is the first to explore the therapeutic potential of tRNA in this way, aiming to unlock new treatment options for patients with specific genetic disorders. The goal of Alltrna is to provide effective treatments that target the root causes of diseases, improving the quality of life for those affected.

Company Stage

Series B

Total Funding

$154.7M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-12%

2 year growth

23%
Simplify Jobs

Simplify's Take

What believers are saying

  • Raised $109M in Series B to advance tRNA medicines for Stop Codon Disease.
  • Growing interest in RNA technologies boosts Alltrna's market potential.
  • FDA's fast-tracking of RNA therapies suggests favorable regulatory conditions.

What critics are saying

  • Emerging competition in tRNA therapeutics could challenge Alltrna's market position.
  • Ethical scrutiny over genetic manipulation may delay product approvals.
  • High development costs could impact financial sustainability if adoption is slow.

What makes Alltrna unique

  • Alltrna is the first to decode tRNA biology for therapeutic use.
  • Their platform uses AI/ML to enhance tRNA therapeutic development.
  • Alltrna targets diseases caused by nonsense mutations with innovative tRNA solutions.

Help us improve and share your feedback! Did you find this helpful?